Comments

Capricor Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CAPRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Tue May 13th, after the market close

The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast

Capricor Therapeutics (CAPR) Forecast

News Earnings Capricor Therapeutics (CAPR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Capricor Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CAPR | Benzinga

Explore Capricor Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CAPR.

Open	-
Close	-
Volume / Avg.	17.40K / 1.99M
Day Range	- - -
52 Wk Range	3.52 - 23.40
Market Cap	$487.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	25.74%
Days to Cover	7.49

Recent News

New FDA Leadership Could Raise The Bar For Drug Approvals

A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

James Gornick

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation

FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.

Vandana Singh

uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	17.40K / 1.99M
Day Range	- - -
52 Wk Range	3.52 - 23.40
Market Cap	$487.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	25.74%
Days to Cover	7.49

About Capricor Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of tr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Capricor Therapeutics (CAPR) stock?

You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.

View our list of the best stock brokerages

Who are Capricor Therapeutics (CAPR) competitors?

Other companies in Capricor Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Cogent Biosciences (NASDAQ:COGT) and Upstream Bio (NASDAQ:UPB).

What is the forecast, or price target, for Capricor Therapeutics (CAPR) stock?

Capricor Therapeutics has a consensus price target of $39.29.

What is the current price for Capricor Therapeutics (CAPR)?

The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $10.66 last updated May 20, 2025 at 9:16 AM EDT.

Does Capricor Therapeutics (CAPR) pay a dividend?

There are no upcoming dividends for Capricor Therapeutics.

When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?

Capricor Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Capricor Therapeutics (CAPR) going to split?

There is no upcoming split for Capricor Therapeutics.

What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.